Previous 10 | Next 10 |
Alkermes Plc ( NASDAQ: ALKS ) rose 2.6% amid speculation that activist Sarissa Capital Management could target the company in a possible proxy battle after a win on Tuesday against Amarin ( AMRN ). Sarissa, which is one of Alkermes ( ALKS ) biggest holders with 14 million ...
If you’re making a list of penny stocks to buy, you have plenty to choose from. In the stock market today, volatility has created a higher-risk environment to trade in. With that, those well-versed in stocks that perform well during times like these have benefited. Penny stocks are...
Amarin Corporation plc (AMRN) Q4 2022 Results Conference Call March 1, 2023 08:00 AM ET Company Participants Lisa DeFrancesco - Senior Vice President, Corporate Affairs and Investor Relations Karim Mikhail - President and Chief Executive Officer Tom Reilly - Chief Fina...
Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q4 2022 Earnings Call Mar 01, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q4 2022 Earnings Call Transcript
Amarin press release ( NASDAQ: AMRN ): Q4 Non-GAAP EPS of $0.02 beats by $0.02 . Revenue of $90.25M (-37.5% Y/Y) beats by $1.07M . For further details see: Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M
-- Company Delivers Positive Free Cash Flow in Fourth Quarter 2022 Following U.S. Revenue Stabilization -- -- Previously Announced Cost Savings Program On-Track to Exceed $100 Million Target -- -- European, International Strategies Advancing At-Pace with Significant Progress Thr...
Summary Positive cash flow in the U.S. for the 3rd quarter. European launch of VASCEPA began in the 4th quarter. Amarin came under new management in 2021. For further details see: Positive Events Are Lining Up At Amarin
Despite a mixed performance for the overall markets during Tuesday's midday trading, the release of quarterly results provided notable trading fodder for many individual stocks. This included Gogo ( NASDAQ: GOGO ) and Progyny ( PGNY ), which surged in the wake of their respective quar...
Amarin ( NASDAQ: AMRN ) is scheduled to announce Q4 earnings results on Wednesday, March 1st, before market open. The consensus EPS Estimate is $0.00 (-100.0% Y/Y) and the consensus Revenue Estimate is $89.18M (-38.3% Y/Y). Over the last 2 years, AMRN has beaten EPS estimate...
Amarin Corp. ( NASDAQ: AMRN ) shares are up ~8% in Tuesday afternoon trading after Sarissa Capital Management, the company's largest shareholder, had seven of its backed individuals elected to the board and current chairman Per Wold-Olsen tossed. The new board will have 15 members...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...